BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 10322660)

  • 1. Studies on the creatine kinase MM isoforms of normal and Duchenne muscular dystrophic patients.
    Zhao X; Bi C; Yang Z
    Chin Med J (Engl); 1998 Jan; 111(1):75-7. PubMed ID: 10322660
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase activity in normal and Duchenne muscular dystrophy fibroblasts.
    Davis MH; Cappel R; Vester JW; Samaha FJ; Gruenstein E
    Muscle Nerve; 1982 Jan; 5(1):1-6. PubMed ID: 7057800
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Muscle and serum enzymes and isoenzymes in muscular dystrophies.
    Ibrahim GA; Zweber BA; Awad EA
    Arch Phys Med Rehabil; 1981 Jun; 62(6):265-9. PubMed ID: 7235920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Electrophoresis of creatine kinase isoforms: a highly sensitive fluorescence scanning method.
    Zhao X; Bi C; Yang Z
    Chin Med J (Engl); 1999 Apr; 112(4):312-5. PubMed ID: 11593528
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum CK-MB activity in progressive muscular dystrophy: is it of nosologic value?
    Vainzof M; Zatz M; Otto PA
    Am J Med Genet; 1985 Sep; 22(1):81-7. PubMed ID: 4050853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mathematical analysis of creatine kinase activity in the course of Duchenne muscular dystrophy.
    Pernice W; Guggolz MA; Guggolz M; Beckmann R; Wais U
    Muscle Nerve; 1986 May; 9(4):333-40. PubMed ID: 3713738
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum myoglobin in muscular dystrophy.
    Kagen LJ; Moussavi S; Miller SL; Tsairis P
    Muscle Nerve; 1980; 3(3):221-6. PubMed ID: 7374673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of carrier detection rates for Duchenne and Becker muscular dystrophies using serum creatine-kinase (CK) and pyruvate-kinase (PK) through discriminant analysis.
    Zatz M; Otto PA
    Am J Med Genet; 1986 Oct; 25(2):219-30. PubMed ID: 3777019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of correlation between skewed X inactivation in blood and serum creatine-kinase levels in Duchenne/Becker female carriers.
    Sumita DR; Vainzof M; Campiotto S; Cerqueira AM; Cánovas M; Otto PA; Passos-Bueno MR; Zatz M
    Am J Med Genet; 1998 Dec; 80(4):356-61. PubMed ID: 9856563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes of serum creatine kinase levels in children with Duchenne muscular dystrophy].
    Sun SC; Peng YS; He JB
    Zhongguo Dang Dai Er Ke Za Zhi; 2008 Feb; 10(1):35-7. PubMed ID: 18289468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum myoglobin in Duchenne muscular dystrophy carrier detection: a comparison with creatine kinase and hemopexin using logistic discrimination.
    Percy ME; Pichora GA; Chang LS; Manchester KE; Andrews DF
    Am J Med Genet; 1984 Jun; 18(2):279-87. PubMed ID: 6465202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection and identification of myoglobin in serum by immunoblotting. Effect of exercise on patients with Duchenne muscular dystrophy.
    Pöche H; Hopfenmüller W; Hoffmann M
    Clin Physiol Biochem; 1987; 5(2):103-11. PubMed ID: 3304774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigation on genetic heterogeneity in Duchenne muscular dystrophy.
    Rabbi-Bortolini E; Zatz M
    Am J Med Genet; 1986 May; 24(1):111-7. PubMed ID: 3706399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cysteine and metalloproteinase activities in serum of Duchenne muscular dystrophic genotypes.
    Sohar I; Laszlo A; Gaal K; Mechler F
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():277-9. PubMed ID: 3202967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Differential diagnosis of Becker and Duchenne muscular dystrophy].
    Alvarez Leal M; Hernández Sifuentes PM; Pérez-Zuno JA
    Gac Med Mex; 1994; 130(6):454-8. PubMed ID: 7557060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An examination of some factors influencing creatine kinase in the blood of patients with muscular dystrophy.
    Jackson MJ; Round JM; Newham DJ; Edwards RH
    Muscle Nerve; 1987 Jan; 10(1):15-21. PubMed ID: 3561434
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.